QXO (QXO) had the highest return between November 1, 2023 and January 31, 2024 by a US stock with a market cap of $2B+, returning 322.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
QXO (QXO) | 11/1/2023 - 1/31/2024 | 322.54% |
Vera Therapeutics (VERA) | 11/1/2023 - 1/31/2024 | 249.52% |
Kymera Therapeutics (KYMR) | 11/1/2023 - 1/31/2024 | 185.54% |
Edgewise Therapeutics (EWTX) | 11/1/2023 - 1/31/2024 | 180.35% |
Trump Media & Technology (DJT) | 11/1/2023 - 1/31/2024 | 153.85% |
Viking Therapeutics (VKTX) | 11/1/2023 - 1/31/2024 | 147.84% |
Oscar Health (OSCR) | 11/1/2023 - 1/31/2024 | 146.46% |
Avidity Biosciences (RNA) | 11/1/2023 - 1/31/2024 | 136.56% |
TransMedics (TMDX) | 11/1/2023 - 1/31/2024 | 130.63% |
Affirm (AFRM) | 11/1/2023 - 1/31/2024 | 128.87% |
Cytokinetics (CYTK) | 11/1/2023 - 1/31/2024 | 123.68% |
Super Micro Computer (SMCI) | 11/1/2023 - 1/31/2024 | 119.48% |
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS) | 11/1/2023 - 1/31/2024 | 118% |
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) | 11/1/2023 - 1/31/2024 | 112.73% |
GeneDx (WGS) | 11/1/2023 - 1/31/2024 | 110.38% |
Twist Bioscience (TWST) | 11/1/2023 - 1/31/2024 | 106.24% |
Flex (FLEX) | 11/1/2023 - 1/31/2024 | 103.51% |
Summit Therapeutics (SMMT) | 11/1/2023 - 1/31/2024 | 97.98% |
Soleno Therapeutics (SLNO) | 11/1/2023 - 1/31/2024 | 96.4% |
Apogee Therapeutics, Inc Common Stock (APGE) | 11/1/2023 - 1/31/2024 | 96.14% |
ZIM Integrated Shipping Services (ZIM) | 11/1/2023 - 1/31/2024 | 93.8% |
SpringWorks Therapeutics (SWTX) | 11/1/2023 - 1/31/2024 | 92.54% |
Grupo Financiero Galicia SA ADR (GGAL) | 11/1/2023 - 1/31/2024 | 91.75% |
CleanSpark (CLSK) | 11/1/2023 - 1/31/2024 | 91.67% |
Rhythm Pharmaceuticals (RYTM) | 11/1/2023 - 1/31/2024 | 91.53% |
